Cargando…
In vitro Antibacterial Activity of an FDA-Approved H(+)-ATPase Inhibitor, Bedaquiline, Against Streptococcus mutans in Acidic Milieus
BACKGROUND: Dental caries is an acid-related disease. Current anti-caries agents mainly focus on the bacteriostatic effect in a neutral environment and do not target acid-resistant microorganisms related to caries in acidic milieus. OBJECTIVES: To assess the in vitro antibacterial activities of beda...
Autores principales: | Zhang, Meng, Yu, Wenqian, Zhou, Shujing, Zhang, Bing, Lo, Edward Chin Man, Xu, Xin, Zhang, Dongjiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947916/ https://www.ncbi.nlm.nih.gov/pubmed/33717046 http://dx.doi.org/10.3389/fmicb.2021.647611 |
Ejemplares similares
-
Bedaquiline: First FDA-approved tuberculosis drug in 40 years
por: Mahajan, Rajiv
Publicado: (2013) -
FDA approved antibacterial drugs: 2018-2019
por: Andrei, Stefan, et al.
Publicado: (2019) -
Involvement of ClpE ATPase in Physiology of Streptococcus mutans
por: Biswas, Saswati, et al.
Publicado: (2021) -
New FDA approved antibacterial drugs: 2015-2017
por: Andrei, Stefan, et al.
Publicado: (2018) -
From Affective Arrangements to Affective Milieus
por: Schuetze, Paul
Publicado: (2021)